Institute Jules Bordet
Anderlecht 1070
1 studies enrolling now · 1 studies all time
What they study most
Metastatic HER2-positive Breast Cancer
Studies at this site
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
— Recruiting now